Thor Medical ASA (OSL:TRMED)

Norway · Delayed Price · Currency is NOK

4.320

-0.020 (-0.46%)

Jun 4, 2026, 10:40 AM CET

77.41% (1Y)

Market Cap	1.57B +100.7%
Revenue (ttm)	839.00K
Net Income	-58.01M
EPS	-0.17
Shares Out	361.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	317,273
Open	4.355
Previous Close	4.340
Day's Range	4.300 - 4.365
52-Week Range	2.290 - 5.730
Beta	-0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 18

Stock Exchange Oslo Børs

Ticker Symbol TRMED

Full Company Profile

Financial Performance

Financial Statements

News

Thor Medical ASA Earnings Call Transcript: H2 2025

AlphaOne remains on track for Q3 2025 production, supported by a NOK 850 million order backlog and strong market demand. The company is fully funded through ramp-up, with initial revenues validating technology and a clear path to profitability by 2027.

3 months ago - Transcripts

Thor Medical ASA Annual report: H2 2025

Thor Medical ASA has published its H2 2025 annual report on February 26, 2026.

3 months ago - Filings

Thor Medical ASA Quarterly report: H2 2025

Thor Medical ASA has published its H2 2025 quarterly earnings report on February 26, 2026.

3 months ago - Filings

Thor Medical ASA Slides: H2 2025

Thor Medical ASA has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.

3 months ago - Filings

Thor Medical ASA Earnings Call Transcript: H1 2025

First commercial sales and major strategic agreements validate technology and market position. AlphaOne plant is fully funded, on schedule for 2026, and capacity was expanded by 40% after a successful capital raise. Revenue potential is strong, with a NOK 770 million order backlog and ambitious growth plans.

9 months ago - Transcripts

Thor Medical ASA Quarterly report: H1 2025

Thor Medical ASA has published its H1 2025 quarterly earnings report on August 29, 2025.

9 months ago - Filings

Thor Medical ASA Slides: H1 2025

Thor Medical ASA has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 29, 2025.

9 months ago - Filings